These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 2237217)
21. Abdominal pain and bacterial meningitis in a previously healthy young adult. Riedel DJ; Roddy KM; Sajadi MM Clin Infect Dis; 2008 May; 46(9):1458, 1479-80. PubMed ID: 18419455 [No Abstract] [Full Text] [Related]
22. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1. Satoh M; Kiyuna S; Shiroma Y; Toma H; Kokaze A; Sato Y Clin Exp Immunol; 2003 Sep; 133(3):391-6. PubMed ID: 12930366 [TBL] [Abstract][Full Text] [Related]
23. Strongyloidiasis presenting as duodenal obstruction in a patient infected with human T-cell lymphotropic virus type 1. Hindy P; Parvin R; Hanna K; Gress F Gastrointest Endosc; 2011 Aug; 74(2):439-41. PubMed ID: 21704987 [No Abstract] [Full Text] [Related]
24. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1). Lambertucci JR; Leão FC; Barbosa AJ Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738 [No Abstract] [Full Text] [Related]
25. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761 [TBL] [Abstract][Full Text] [Related]
26. Utility of PCR in Patients with Blaizot R; Simon S; Brottier J; Blanchet D; Brousse P; Boukhari R; Demar M Am J Trop Med Hyg; 2019 Oct; 101(4):848-850. PubMed ID: 31436152 [No Abstract] [Full Text] [Related]
27. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels. Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560 [TBL] [Abstract][Full Text] [Related]
28. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Gabet AS; Mortreux F; Talarmin A; Plumelle Y; Leclercq I; Leroy A; Gessain A; Clity E; Joubert M; Wattel E Oncogene; 2000 Oct; 19(43):4954-60. PubMed ID: 11042682 [TBL] [Abstract][Full Text] [Related]
29. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis]. Porto MA; Muniz A; Oliveira Júnior J; Carvalho EM Rev Soc Bras Med Trop; 2002; 35(6):641-9. PubMed ID: 12612748 [TBL] [Abstract][Full Text] [Related]
30. Antibodies to Strongyloides stercoralis in healthy Jamaican carriers of HTLV-1. Nera FA; Murphy EL; Gam A; Hanchard B; Figueroa JP; Blattner WA N Engl J Med; 1989 Jan; 320(4):252-3. PubMed ID: 2911314 [No Abstract] [Full Text] [Related]
31. [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis]. Foucan L; Genevier I; Lamaury I; Strobel M Med Trop (Mars); 1997; 57(3):262-4. PubMed ID: 9513154 [TBL] [Abstract][Full Text] [Related]
32. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers? Arakaki T; Asato R; Ikeshiro T; Sakiyama K; Iwanaga M Trop Med Parasitol; 1992 Sep; 43(3):199-200. PubMed ID: 1470843 [TBL] [Abstract][Full Text] [Related]
33. [Klebsiella pneumoniae meningitis, Strongyloides stercoralis infection and HTLV-1]. Troncoso García E; Muñoz Medina L; Callejas Rubio JL; López Ruz MA Med Clin (Barc); 2000 Jun; 115(4):158. PubMed ID: 10996890 [No Abstract] [Full Text] [Related]
34. Image of the month: Target the bugs: Hokama A; Kishimoto K Clin Med (Lond); 2021 Mar; 21(2):e239-e240. PubMed ID: 33762395 [TBL] [Abstract][Full Text] [Related]
35. Strongyloidiasis: a diagnosis more common than we think. Koczka CP; Hindy P; Goodman A; Gress F Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):860-2. PubMed ID: 22555259 [TBL] [Abstract][Full Text] [Related]
36. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Newton RC; Limpuangthip P; Greenberg S; Gam A; Neva FA Am J Med; 1992 Feb; 92(2):202-8. PubMed ID: 1543206 [TBL] [Abstract][Full Text] [Related]
37. Strongyloidiasis: a mistaken diagnosis and a fatal outcome in a patient with diarrhoea. Rahim S; Drabu Y; Jarvis K; Melville D Trans R Soc Trop Med Hyg; 2005 Mar; 99(3):215-7. PubMed ID: 15653124 [TBL] [Abstract][Full Text] [Related]
38. Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan. Sato Y; Shiroma Y; Kiyuna S; Toma H; Kobayashi J Trans R Soc Trop Med Hyg; 1994; 88(1):59. PubMed ID: 8154005 [No Abstract] [Full Text] [Related]
39. Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected host. Friedenberg F; Wongpraparut N; Fischer RA; Gubernick J; Zaeri N; Eiger G; Ozden Z Dig Dis Sci; 1999 Jun; 44(6):1184-8. PubMed ID: 10389694 [No Abstract] [Full Text] [Related]
40. Septic Meningitis and Liver Abscess due to Hypermucoviscous Klebsiella pneumoniae Complicated with Chronic Strongyloidiasis in a Human T-lymphotropic Virus 1 Carrier. Hosoda T; Sakamoto M; Orikasa H; Kubomura A; Misaki T; Okabe N Intern Med; 2020 Jan; 59(1):129-133. PubMed ID: 31434825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]